Neurological Devices Panel meeting postponed
This article was originally published in The Gray Sheet
Executive Summary
FDA postpones Oct. 31 meeting of Neurological Devices Advisory Panel to a date yet to be determined. The panel will review clinical data and discuss questions about Neuronetics' NeuroStar TMS system as a potential treatment for depression, says Peter Anastasiou, the company's VP-marketing. CDRH "will further evaluate data relevant to the topic," according to the agency's website...